2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Reverse Medical to Study Barrel VRD to Treat Intracranial Bifurcation Aneurysms

April 15, 2014—Reverse Medical Corporation (Irvine, CA) announced that the US Food and Drug Administration approved an investigational device exemption for a clinical st…

Covidien Recalls Pipeline and Alligator Devices

April 11, 2014—Covidien (Mansfield, MA) announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization…

Alvimedica Launches Cre8 BTK Drug-Eluting Stent in Europe

April 7, 2014—Alvimedica Medical Technologies (Catalca, Turkey) announced the launch of the Cre8 BTK drug-eluting stent (DES), a polymer-free device for the treatment of…

CE Mark Approval of Vascutek’s Anaconda AAA System Expanded for Use in Tortuous Anatomy

April 7, 2014—Vascutek (Inchinnan, United Kingdom) announced that European CE Mark approval for the Anaconda abdominal aortic aneurysm (AAA) stent graft system has been …

Click here for more News coverage

Current Supplements

Sponsored by Boston Scientific Corporation

Master the Cross

Leading endovascular experts describe the many techniques and tools required to conquer the challenges of CTOs in PVD.

Sponsored by Medtronic, Inc.

Refining Strategies for the SFA

A panel of experts discusses the promise of drug-eluting balloons and other techniques for treating SFA and popliteal lesions.

Featured Center



Featured Video

EVAR in a Patient With Severe Aortoiliac Disease




Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media